stock price decline

Class action lawsuit filed against $IT over alleged misleading growth projections. Stock fell 27.55% and 20.87% after earnings misses. Lead plaintiff deadline May 18, 2026.

The Gross Law Firm filed a securities class action against $COTY for allegedly misleading investors about financial performance. Stock fell 22% after weak Q2 results.

Robbins LLP reminds investors of June 9, 2026 deadline to join class action against United Homes Group over allegedly misleading sale to Stanley Martin Homes at steep discount.

Rosen Law Firm investigates GSI Technology for alleged AI chip misrepresentation, sparking 14.2% stock decline and potential securities lawsuit.

CarMax shares hit 5-year lows amid margin compression, weak demand, and intense digital competition. Analysts maintain Reduce ratings as fundamental challenges persist.

Portnoy Law Firm launches class action against $IMNB following failed Phase 2 glioblastoma trial, citing investor losses from steep stock decline.

Immutep's stock crashed to $0.48 after its independent monitoring committee halted the TACTI-004 Phase III trial for eftilagimod alfa due to futility, prompting legal investigation.

United Homes Group plummets 52% after agreeing to $1.18/share acquisition; shareholders sue controlling shareholder over alleged misrepresentation.

Pomerantz LLP filed class action against $IT for alleged securities fraud tied to two major stock declines. Investors have until May 18, 2026, to join the lawsuit.

Pomerantz Law Firm files class action suit against $RGNX after FDA clinical hold on gene therapy candidates triggers 17.9% stock collapse. Investor deadline: April 14, 2026.

NuScale Power faces class action lawsuit alleging material misstatements about ENTRA1 partnership. Stock fell 12.4% post-disclosure; lead plaintiff deadline set for April 2026.

Portnoy Law Firm investigates Beta Bionics for possible securities fraud after stock plummets 37% on disappointing Q4 2025 results showing user acquisition growth halved to 36%.

Portnoy Law Firm files class action against $SNOW for allegedly concealing negative impact of product efficiency gains on revenues. Stock fell 18% post-disclosure.

Law firm Kirby McInerney reminds Eos Energy investors of May 5, 2026 deadline to join securities lawsuit alleging missed guidance and disclosure failures.

$GSIT shares fell 14.2% after legal investigation into allegedly misleading AI chip capability claims. Class action lawsuits being prepared to recover shareholder losses.

Aquestive Therapeutics faces class action lawsuit alleging FDA approval misrepresentations for Anaphylm. Stock dropped 37% January 9; lead plaintiff applications due May 4, 2026.

Hub Group ($HUBG) revealed accounting errors in Q1-Q3 2025 results, requiring restatement. Stock fell 18.3% after disclosure; law firm investigating shareholder claims.

Gossamer Bio faces securities fraud lawsuit after stock plummets 80% following disclosure of allegedly undisclosed Latin American trial site enrollment practices that compromised Phase 3 study results. Lead plaintiff deadline is June 1, 2026.

Driven Brands faces class action lawsuit over accounting restatement for fiscal 2023-2024. Stock plummeted 40% after disclosure of lease, cash, and revenue errors.

ImmunityBio faces securities fraud lawsuit after FDA warning over false Anktiva claims. Stock plunged 21%. Investor deadline May 26, 2026.